Tomohiro Mizuno

1.0k total citations
69 papers, 772 citations indexed

About

Tomohiro Mizuno is a scholar working on Nephrology, Geriatrics and Gerontology and Pharmacology. According to data from OpenAlex, Tomohiro Mizuno has authored 69 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Nephrology, 13 papers in Geriatrics and Gerontology and 12 papers in Pharmacology. Recurrent topics in Tomohiro Mizuno's work include Pharmaceutical Practices and Patient Outcomes (13 papers), Pharmacy and Medical Practices (10 papers) and Complement system in diseases (7 papers). Tomohiro Mizuno is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (13 papers), Pharmacy and Medical Practices (10 papers) and Complement system in diseases (7 papers). Tomohiro Mizuno collaborates with scholars based in Japan, United States and United Kingdom. Tomohiro Mizuno's co-authors include Yukihiro Noda, Masashi Mizuno, Yasuhiko Ito, Seiichi Matsuo, Shoichi Maruyama, Enyu Imai, Fumihiro Mizokami, Yasuhíro Suzuki, Tadashi Nagamatsu and Kazuo Takahashi and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Tomohiro Mizuno

59 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomohiro Mizuno Japan 16 209 161 150 128 111 69 772
Dae Hyun Lee United States 14 176 0.8× 147 0.9× 193 1.3× 74 0.6× 81 0.7× 53 947
Tomás P. Griffin Ireland 17 134 0.6× 214 1.3× 168 1.1× 99 0.8× 135 1.2× 52 853
Kostas Stylianou Greece 19 361 1.7× 137 0.9× 215 1.4× 86 0.7× 71 0.6× 77 1.0k
Aimin Liu China 19 281 1.3× 207 1.3× 231 1.5× 112 0.9× 92 0.8× 76 985
Masahiro Eriguchi Japan 15 324 1.6× 151 0.9× 129 0.9× 53 0.4× 93 0.8× 60 780
Anita Mehrotra United States 16 212 1.0× 183 1.1× 118 0.8× 141 1.1× 68 0.6× 32 861
Catalina Martín-Cleary Spain 18 489 2.3× 154 1.0× 251 1.7× 131 1.0× 42 0.4× 29 995
Hoon Suk Park South Korea 15 204 1.0× 150 0.9× 160 1.1× 90 0.7× 82 0.7× 49 779
Oleh M. Akchurin United States 13 469 2.2× 123 0.8× 299 2.0× 126 1.0× 57 0.5× 24 1.1k
Fatih Bulucu Türkiye 16 66 0.3× 136 0.8× 92 0.6× 95 0.7× 69 0.6× 52 688

Countries citing papers authored by Tomohiro Mizuno

Since Specialization
Citations

This map shows the geographic impact of Tomohiro Mizuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohiro Mizuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohiro Mizuno more than expected).

Fields of papers citing papers by Tomohiro Mizuno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohiro Mizuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohiro Mizuno. The network helps show where Tomohiro Mizuno may publish in the future.

Co-authorship network of co-authors of Tomohiro Mizuno

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohiro Mizuno. A scholar is included among the top collaborators of Tomohiro Mizuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohiro Mizuno. Tomohiro Mizuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mizuno, Tomohiro, et al.. (2024). Factors necessary for a community pharmacist to achieve interprofessional collaboration in home‐based care in Japan. Geriatrics and gerontology international. 24(10). 1008–1014. 1 indexed citations
2.
Matsumoto, Noriaki, Tomohiro Mizuno, Koki Kato, et al.. (2024). Prediction Model for Severe Thrombocytopenia Induced by Gemcitabine Plus Cisplatin Combination Therapy in Patients with Urothelial Cancer. Clinical Drug Investigation. 44(5). 357–366. 2 indexed citations
3.
Mizuno, Tomohiro, Fumihiko Nagano, Kazuo Takahashi, et al.. (2024). Macrophage‐1 antigen exacerbates histone‐induced acute lung injury and promotes neutrophil extracellular trap formation. FEBS Open Bio. 14(4). 574–583. 5 indexed citations
4.
Mizokami, Fumihiro, Tomohiro Mizuno, Sayaka Arai, et al.. (2024). Development of the Japanese Anticholinergic Risk Scale: English translation of the Japanese article. Geriatrics and gerontology international. 25(1). 5–13. 2 indexed citations
5.
Koseki, Takenao, Takuma Ishihara, Takao Tobe, et al.. (2023). Influence of Brain Metastasis on Analgesia-Related Outcomes in Patients with Lung and Breast Cancers Treated with Naldemedine: A Propensity Score-Matched Analysis. Journal of Clinical Medicine. 12(22). 6997–6997. 2 indexed citations
6.
7.
Mizuno, Tomohiro, Fumihiko Nagano, Yoshimasa Ito, et al.. (2023). Novel function of transglutaminase 2 in extracellular histone-induced acute lung injury. Biochemical and Biophysical Research Communications. 678. 179–185. 1 indexed citations
8.
Mizokami, Fumihiro, et al.. (2023). Investigation of geriatric syndromes associated with medication in Japan using insurance claims data. Geriatrics and gerontology international. 24(1). 61–67.
9.
Mizuno, Tomohiro. (2023). The Functional Roles and the Potential as Drug Targets of Glycoproteins Regulating Complement and Coagulation Pathways. YAKUGAKU ZASSHI. 143(9). 707–712. 1 indexed citations
10.
11.
Mizuno, Tomohiro, Takeshi Ikeda, Fumihiro Mizokami, et al.. (2022). Prediction model of acute kidney injury induced by cisplatin in older adults using a machine learning algorithm. PLoS ONE. 17(1). e0262021–e0262021. 15 indexed citations
12.
Nagano, Fumihiko, Tomohiro Mizuno, Masaki Imai, et al.. (2021). Expression of a Crry/p65 is reduced in acute lung injury induced by extracellular histones. FEBS Open Bio. 12(1). 192–202. 5 indexed citations
13.
Nakanishi, Masanori, Tomohiro Mizuno, Fumihiro Mizokami, et al.. (2020). Impact of pharmacist intervention for blood pressure control in patients with chronic kidney disease: A meta‐analysis of randomized clinical trials. Journal of Clinical Pharmacy and Therapeutics. 46(1). 114–120. 11 indexed citations
14.
Yamaguchi, Hisateru, Kazuki Nakajima, Tomohiro Mizuno, et al.. (2020). Analysis of O-glycoforms of the IgA1 hinge region by sequential deglycosylation. Scientific Reports. 10(1). 671–671. 26 indexed citations
15.
Mizuno, Tomohiro, Kazuo Takahashi, Fumihiko Nagano, et al.. (2020). CD140b and CD73 are markers for human induced pluripotent stem cell‐derived erythropoietin‐producing cells. FEBS Open Bio. 10(3). 427–433. 5 indexed citations
16.
Mizuno, Tomohiro, Masashi Mizuno, Mie Shimizu, et al.. (2017). Complement component 5 promotes lethal thrombosis. Scientific Reports. 7(1). 42714–42714. 28 indexed citations
17.
18.
Mizuno, Tomohiro, Takahiro Hayashi, Rina Kato, et al.. (2014). Risk factors for an early dialysis start in patients with diabetic nephropathy end-stage renal disease. Therapeutics and Clinical Risk Management. 10. 73–73. 2 indexed citations
19.
Mizuno, Masashi, Yasuhiko Ito, Tomohiro Mizuno, et al.. (2009). Zymosan, but Not Lipopolysaccharide, Triggers Severe and Progressive Peritoneal Injury Accompanied by Complement Activation in a Rat Peritonitis Model. The Journal of Immunology. 183(2). 1403–1412. 33 indexed citations
20.
Kato, Hiroshi, Akira Yoshimi, Tomohiro Mizuno, et al.. (2009). Practical Clinical Pharmacy Training through Cooperation between Medical and Pharmaceutical Schools: Resident Faculty-led Practical Training Employing "Age-mixing Method". Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 35(1). 24–30. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dae Hyun Lee Breakdown of academic impact, for papers by Tomás P. Griffin Breakdown of academic impact, for papers by Kostas Stylianou Breakdown of academic impact, for papers by Aimin Liu Breakdown of academic impact, for papers by Masahiro Eriguchi Breakdown of academic impact, for papers by Anita Mehrotra Breakdown of academic impact, for papers by Catalina Martín-Cleary Breakdown of academic impact, for papers by Hoon Suk Park Breakdown of academic impact, for papers by Oleh M. Akchurin Breakdown of academic impact, for papers by Fatih Bulucu
Rankless by CCL
2026